CS MEDICA A/S: Notice of Shareholders’ Annual General Meeting
The shareholders of CS MEDICA A/S are hereby notified of the Annual General Meeting that will be held on Friday, February 28, 2025, at 15:00 CET, at TEAMS
The shareholders of CS MEDICA A/S (“CS MEDICA” or the “Company”) are hereby notified of the Annual General Meeting that will be held on Friday, February 28, 2025, at 15:00 CET, via TEAMS.
Agenda:
- Election of Chairman of the Meeting.
- Presentation of the Annual Report with Auditors’ Report for Adoption.
- Resolution Concerning the Appropriation of Losses as Recorded in the Adopted Annual Report.
- Election of Members to the Board of Directors.
- Election of the Company’s Auditor.
- Any Other Business.
The total number of votes as of the date of this notice is 17.125.827.
Additional Information:
- Annual Report with Auditors’ Report: The annual report, will be presented for adoption and signatur.
- Appropriation of Losses: The board proposes that the result for the period 1 October 2023 – 30 September 2023 (DKK -9,650,907) be carried forward to the following year.
- Election of Members to the Board of Directors: The board is repositioned by Mads Jørgensen and Torben Jørgensen.
- Re-election of Auditor: The board proposes that Christensen Kjærulff Statsautoriseret Revisionsaktieselskab be re-elected as the Company’s auditor.
- Amendment to the Articles of Association (Section 6.1):
The board proposes the following amendment to Section 6.1 of the Articles of Association, which is subject to approval by the shareholders at the AGM:- Current wording: “The board of directors consists of no less than four and no more than eight members elected by the general meeting.”
- Proposed amendment: “The board of directors will consist of no less than two members.”
Sign up for the Annual General Meeting: To attend the AGM, please send an email to info@cs-medica.com.
Registration Deadline: The registration date is 20 February 2025. Only shareholders on this date are entitled to participate and vote at the AGM.
Proxy and Postal Voting: Shareholders may authorize a proxy holder to attend the AGM on their behalf. Such requests must be made by 26 February 2025, 11:59 PM (CET), in accordance with Section 5.9 of the Articles of Association. Proxy and postal voting forms are available on the Company’s website at www.cs-medica.com.
Participation: Shareholders whose shares are held by a nominee must ensure their shares are re-registered in their name in the share register by 20 February 2025.
Shareholder Questions: Shareholders have the right to ask questions about the agenda items. These can be submitted in writing prior to the AGM or raised during the meeting. Responses will be provided at the meeting or within two weeks following the AGM.
Contact Information: All relevant AGM material, including the agenda and voting forms, can be obtained from Gitte Lund at glh@cs-medica.com. The material will be sent by email only; please ensure your email address is specified.
For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/
About CS MEDICA A/S
Founded in 2011, CS MEDICA is a Danish MedTech company specializing in CBD-infused treatments for autoimmune and stress-related conditions, including arthritis, psoriasis, and pain management. Operating at the intersection of the pharmaceutical and cosmetics industries, CS MEDICA delivers clinically supported products with fewer side effects, offering competitive and accessible alternatives. With MDR-approved products, cutting-edge R&D, and the benefits of CBD, the company provides innovative, safe, and effective solutions. Its capital-light business model and trusted European production partners further enhance its ability to offer high-quality treatments, setting CS MEDICA apart in the MedTech sector.
